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Background:A highplasmahomocyateineis an independentriskfactorfor
coronatyarterydisease(CAD).In normalsubjects,homocysteinemaybe
reducedwithfolicacid,vitaminB6andB12.
Aim and Method:To studythe effectof differentdosesof folicacidon
homocysteineconcentrationsin mronafy arterydisease,78 patients(62






1 mg or 5 mg of folic acid (seetable).No changewaaobservedin those
giveneitherplaceboor 400Kgfolicacid.
Baseline 1 Month 3 Months
Placsbo 11.0* 1.0 12.4+ 1.0 12.6* 1.0
400 pg folicacid 11.750.8 12.2* 0.8 10.6+20.8
1 mg folicacid 12.7& 0.9 9.5 +0.9’ 9.9 +0.9””
5 mg folicacid 16.4+ 1.1 11.0+ l.lt 10.3 * l.lt
*p <0.01vs. baseline,**p<0.05vs. baseline,t p e 0.001 VS.baseiine
Conclusion:In patientswithmronaryartev disease,homocyeteinemn-
centrationsoan be reducedby administrationof folic acidsupplementsin









of cardiovascularevents.The clusteringof multiplerisk factorssuggests
a commonmetaboliclink betweenhighbl~ Pressure,insulinresis~nce,
plasmalipoproteinabnormalitiesand obesity.Newguidelinesfor the man-
agementof dyslipidemieetargethighrisksubjectswithestablishedCADor
multipleriskfaotore.We examined243 men(M) and 81 women(W)with
prematureCAD,(< 60 years)and 203 age-and gender-matchedcontrols
(152M,61W).Aftercorrectingfor beta-blockeruseHTNandDMwereseen
morefraquentfyin CADsubjectsthan in controls.In menand in women,
cholesterol(C),triglyoeddea,LDL-C,apolipoprotein(ape)B andIipeprotein
(a) [Lp(a)]weresignificantlyhigherand HDL-Clevelswerelowerin cases
than in controls.Wedeviseda metabolicfactorindex,assigninga scoreof
1 eachfor the presenceof HTN,lipoproteinabnormalities,the presenceof
DMor fastingbloodglucose>7.0 mmoVLand a bodymassindexZ-27.
The prevalenceof CADsubjectswitha metabolicfactorindexof ? 3 was
29.2%in CADMva6.7%in controls(p < 0.0001)and36.3Y0 in CAD w Vs
11.7%in controls(p < 0.01).Familialhypercholesterolemiawereseenin <
5%of prematureCADcasesandtype Ill dyslipoproteinerniain 1/343CAD
patients.Thedistributionof apo E phenotypeswasnotdifferentin casesvs
controla.Multivariateanalysisrevealathat in menHDL-C,Lp(a)Ieveisand
smokingarethe beetpredictorsof risk.Inwomen,plasmalevelsof LDL-C,
apoB,triglyceridesor BMIdid notenterthe modelat the p c 0.05level.In
women,a low HDL-C,Lp(a),the presenceof diabetes,smokingandapoB








A.S.P.LR.E.wasa nationalsurveyof eligibilityfor, & practiceof,’secondary
corona~ preventionin the UK. A stratifiedrandomsampleof 12 district
generalhospitalsidentified25 consecutivepatientss 70 yrs old, of each
sex,admittedfor AMI & for acutemyocardialiechaemiawithoutinfarction
[lSCH],? 6 monthspriorto thesurvey.Riskfactordatawereabstractedin a
standardformatretrospectivelyfrommedicalnotes.Patientswereinvitedfor
prospectiveintetview& examination.
717AMI’s& 635 ISCH’Swereascertained.121AMI’s& 3SISCH’Shad
diedbytimeof interview,attendedby489(62%)& 473(79%),reapactively.
Whereas62%of male& 65%of femaleAMI’swere incident(hadno prior
histotyof mronary disease),only 17%of male & 31% of female ISCH’S
wereincident.At interview,currentsmokingwasaimilarin incident(23%)&
recurrent(25%)AMI’s,butwasmorefrequentinincident(31Yo)thanrSCIJt7ent
(25%)ISCH’S.Qverallprevalenceof obeaity(BMIz 30 kgkq.m)wassimilar
foreachsub-group(30%).OverallprevalenceofhypertensionIHrll waa11%
(diastolicz 100mmHg)& 16%(systolicz 180 mmHg).SystolicI-VTwaa
morefrequentin incidentAMI(19.5%vs. 15.3%)& ISCH(23%vs. 15.3%)
casescomparedto recurrent.Overailprevalenceofcholesterol>5.5 remold
was72?4.,& thoughhigherin womenfor both diagnoses,was similarfor
incident& recurrentcases.Overallprevalenceof diabetes(randomblood
glucose>10 mmol/1)was7%andmorefrequentin recurrentcases.
For obeaity,diastolicH/T,smokingin AMI’s& hypercholesterolaemia,







Majorstudieshave now demonstratedmortalitybenefit by reducingtotal
cholesterol (TC) in patients with coronary artery disease (CAD). To evaluate
theeffectofthisrecentdata,456patientsdiagnosedwithCADatacardiology
centrewereasseeeed1995(n= 149)wasmmperedwith1991-93(n=307).
Patientabaselinemanagementwascomparedand in thosewitha TC level
>5.2 mmol/La questionnaireregardingsubsequentmanagementwaasent
to primarycarephysicians.Results:Comparing1995with 91-93 meanTC
wassignificantlyiower(5.7mmo~+ 1.3Vs6.3mmolL+1.2(P < 0.01))and
therewas moreLLTuse (25%Vs 13%P c 0.01)).At followup TC taata
hadbeenperformedin 36%VS32%(notsignificant)and77%Vs46%(P c
0.01)wereon LLT.Amongthosewhohada repeatTCperformed,meanTC
droppadfrom6.4mmo!fLSD0.81to5.5 SD1.1P c 0.01in95, and6.6SD1
to 5.9SD1(P < 0.01)in 91-93.65%patientsinwhomrepeattesthadbeen
performedwereonLLTcomparedwith20%ifa testhadnotbeenperformed
P <0.01. Predictorsof LLTuse werethe year of presentation,followup
testing,andthe uaeof LLTat baseline.Conclusion:Themanagementof TC
hassignificantlyimprovedinpatientsdiagnosedwithCADin 1995compared








differencesin bloodpressureregulationby raoeand sex. Usingrepeatad
assessmentsof systolicand diastolicblood pressuremeasuredat ages
11, 12.5and 14, muitivariategeneticanalyseaexaminedthe contribution
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countfor thevariationin diastolicbloodpressure,butthecontributionof the




ThereWeno significantracaor sexdifferencesin the geneticregulationof
bloodpmssumdurin~adolescence.





disease(CHD),becauseHDL playaa role in the reversecholesterol(C)
transport.Sincemoatof the esterificationof oholestemlin plasmaoccurs
in HDLfraction,the fractionalrate of cholesterolesterificationin low and
verylowdensityIipoproteindepletedplasma(expressedasFERHDL) reflects
the reactivityof HDLto lecithin:cholesterolacyltranfersse(LCAT).FERHOL
hasbeanusedaaa functionalassessmentof HDLhetercgenity.Thevalue
of FERHOLis higherin coronaryarterydiseaseand lowerin LCAT-deficient
patientswhoshowedno evidenceof CHD.In a case[patientswithangio-
graphicallyprovencoronaryatherosclerosis(CA),n = 285]-contml[patients





and mntrols, but the regressionlines interactedbetweenthe two groupa
of patients.A multiplelogisticregressionanalysisindicatedthat oddsratio












































































patients(84 Male, meanage (SD)66 11)years)who preeentedwith ST
depressionduring1990,74 (54%)had confirmedinfarction.The mortality
wee26%atone,3S%atthreeand46%atfiveyeare.Forthe72patientewith
1 mmST depression,the mortalityratewasalmostlinearand significantly
Iowerthanthosewith> 1mmSTdepression(p< 0.01).The5 yearamortality
for >70 y.o.(36deathsin56 patients,84%)wassignificantlyhigherthan c
70 Y.O. (27 deaths, 34?4.,P < 0.01).Thepresenceof Qwavesonadmiseion
(mortality61%v 35%,p < 0.01)andnumberof IeadewithSTdepression(<





Dayaf~;mpres~ntaffon Yeirafr;m p&aent;tfon ‘
Cone/uaion:ECGand clinicalcharacterieticeare helpful in identifying
patientewithpoorshortandlongtermoutcomeendshouldaid in the better
managementof this importantgroupof patients.
